Brief: India's Hester Biosciences June-Qtr Consol Net Profit Falls
July 30 (Reuters) - Hester Biosciences Ltd HEST.NS :
* JUNE-QUARTER CONSOL NET PROFIT 57.2 MILLION RUPEES VERSUS
83.9
MILLION RUPEES YEAR AGO
* JUNE-QUARTER CONSOL TOTAL REVENUE 405.5 MILLION RUPEES
VERSUS
453.3 MILLION RUPEES YEAR AGO
* DEVELOPMENTAL WORK ON-GOING FOR HUMAN COVID-19 VACCINE;
HOPE TO
COMMENCE ANIMAL TRIALS BY END OF THIS CALENDAR YEAR
Source text for Eikon: ID:nBSE8KYykc
Further company coverage: HEST.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hester Biosciences
See all newsIndia's Hester Biosciences jumps on quarterly profit rise
Brief: Hester Biosciences March-Quarter Consol Net Profit 159.8 Million Rupees
India's Hester Biosciences gains on plan to sell stake in Texas Lifesciences
Brief: Hester Biosciences Approves Divestment Of 43.81% Equity In Texas Lifesciences
Brief: Hester Biosciences Re-Appoints Rajiv Gandhi As CEO & MD